Cargando…

Acute neurological AEs after COVID-19 vaccination

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226708/ http://dx.doi.org/10.1007/s40278-022-17710-3

Ejemplares similares

Systemic AEs common after COVID-19 vaccination
Publicado: (2022)

Heterogeneity in potential COVID-19 vaccine-related AEs
Publicado: (2021)

AEs after homologous versus heterologous COVID-19 booster
Publicado: (2022)

AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
Publicado: (2021)

No safety signal after COVID-19 vaccination for immune-mediated neurological events
Publicado: (2022)

Systematic review: COVID-19 vaccine-related neurological disorders "exceedingly" rare
Publicado: (2022)

Acute kidney injury after COVID-19 vaccines: a real-world study
por: Luo, Huiting, et al.
Publicado: (2022)

Pfizer-BioNTech COVID-19 vaccine: AEs after vaccination in New Zealand
Publicado: (2021)

Thrombocytopenia and thromboembolism after COVID-19 vaccination
Publicado: (2021)

Seizures and COVID-19: Results from the Spanish Society of Neurology’s COVID-19 registry
por: Fernández, Santiago Fernández, et al.
Publicado: (2022)

COVID-19 mRNA vaccines: acute allergic reaction and anaphylaxis
Publicado: (2021)

No increased risk for venous thromboembolism after COVID-19 vaccination
Publicado: (2022)

Cerebral venous sinus thrombosis after COVID-19 vaccination
Publicado: (2021)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

COVID-19 vaccine AE reports in Australia and New Zealand
Publicado: (2021)

Rare reports of rheumatic disorder flares after COVID-19 vaccination
Publicado: (2022)

Small change in menstrual cycle length after COVID-19 vaccination
Publicado: (2022)

Expected rates of adverse events after COVID-19 vaccination in USA
Publicado: (2022)

Cerebral vein thrombosis after four COVID-19 vaccines in Europe
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

FAPIC score predicts mortality after COVID-19 vaccine-related TTS
Publicado: (2021)

PRAC May 2021 meeting highlights: COVID-19 vaccine AEs
Publicado: (2021)

PRAC June 2021 meeting highlights: COVID-19 vaccine AEs
Publicado: (2021)

Cardiac risks higher after COVID-19 infection than mRNA vaccine
Publicado: (2022)

Reported rates of CVST due to COVID-19 vaccination rose after publicising these ADRs
Publicado: (2022)

Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination
Publicado: (2021)

Nursing home resident deaths after Pfizer-BioNTech's COVID-19 vaccine
Publicado: (2021)

No increase in stroke, MI or PE after Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

Delayed Neurological Deficits after Osteoporotic Vertebral Fractures: Clinical Outcomes after Surgery
por: Yeung, Yip-Kan, et al.
Publicado: (2017)

WTP for COVID-19 vaccine in Chile
Publicado: (2021)

TTS with Janssen's COVID-19 vaccine
Publicado: (2021)

Younger males at greatest risk of myocarditis after mRNA-based COVID-19 vaccination
Publicado: (2022)

Low risk of myopericarditis after COVID-19 vaccination in children aged 5-11 years
Publicado: (2022)

Mental Fatigue and Cognitive Impairment after an Almost Neurological Recovered Stroke
por: Johansson, Birgitta, et al.
Publicado: (2012)

Humanized CD19-directed CAR-T Cell Therapy in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia With CNSL or Neurological Comorbidity
por: Zhang, Na, et al.
Publicado: (2022)

AES-Comments on AES offer
por: Gerard, M
Publicado: (1986)

Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma
por: Sughrue, Michael E., et al.
Publicado: (2010)

Public's willingness to wait for COVID-19 vaccine
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kuhmg7gfqdlmndsbp4dqmsc5fi